TECHNOLOGY
CONTACT

Evidence
Evidence, Validation, and Real-World Learning
Genie's credibility is built on data — from large-scale measurement processing to structured clinical validation pathways spanning multiple geographies, care settings, and patient populations. We are transparent about what has been validated, what is in progress, and what remains investigational.
3,000,000+ Measurements Processed
Across deployment, development, and validation environments — spanning clinical, senior care, and telehealth contexts.
11,000+ Unique Subjects
Represented across system development, testing, and validation datasets — supporting diversity and generalizability.
Japan Telehealth Experience
Deployment pathway connected to telehealth workflows reaching thousands of clinics and physicians across Japan.
Taiwan Senior Care Ecosystem
Experience supporting senior care monitoring workflows across a large community-based care ecosystem in Taiwan.
Clinical Advisory Input for Higher-Acuity Validation
SGAI HealthLink is receiving clinical strategy guidance from Dr. Scott Helgeson, a Mayo Clinic physician leader, as the company plans higher-acuity validation pathways involving inpatient, ICU, and sepsis-related monitoring scenarios. No institutional endorsement or formal Mayo Clinic deployment is implied.
LCHC / MeHI Pilot Planning
SGAI HealthLink is discussing and developing a proposed pharmacy-based pilot with Lynn Community Health Center and Massachusetts digital health ecosystem partners. This pilot has not yet been deployed.
Evidence
Our Approach to Responsible Evidence
What We Validate
Accuracy, precision, and real-world performance across diverse skin tones, lighting conditions, ages, and care environments. We measure what matters — and report honestly on what we don't yet know.
Accuracy & Precision
Genie's signal processing pipeline is designed with signal quality gating to minimize low-confidence outputs. Accuracy and precision data are context-dependent and disclosed transparently in validation documentation.
Equity & Inclusivity
We are actively working to ensure Genie performs equitably across diverse populations — including across skin tones, ages, and care environments. This is a clinical and ethical priority, not an afterthought.
Regulatory Pathway
SGAI HealthLink is developing its regulatory strategy in alignment with U.S. FDA frameworks and relevant international standards. Regulatory status varies by jurisdiction and intended use. Genie is not yet commercially available in all markets.